OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!

HTML

Year: 2019
Type: review
Source: Metabolism
DOI: 10.1016/j.metabol.2019.154001
Authors: Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar
Institutions: Mashhad University of Medical Sciences, The Royal Free Hospital, University College London
Language: English

Topic: Liver Disease Diagnosis and Treatment
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, pioglitazone, insulin resistance, cardiometabolic risk, NAFLD screening, lifestyle therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2982675229
FWCI: 1.659
Cites: 140
Cited by: 110
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security